Spironolactone 100mg

DRUG6 trials

Conditions

Gender DysphoriaHeart FailureHidradenitis SuppurativaHuman Immunodeficiency VirusNASH - Nonalcoholic SteatohepatitisPatients With Fungic InfectionsRespiratory Distress Syndrome, AdultTransgender Health

Phase 1

Spironolactone Therapy In Young Women With NASH

CompletedNCT03576755

University of California, San FranciscoNASH - Nonalcoholic Steatohepatitis

Start: 2019-01-09End: 2023-07-05Updated: 2025-03-26

Evaluating Drug Interactions Between Doravirine With Estradiol and Spironolactone in Healthy Transgender Women

CompletedNCT04283656

Thomas Jefferson UniversityGender Dysphoria, Human Immunodeficiency Virus, Transgender Health +1

Start: 2022-01-04End: 2022-12-30Updated: 2025-03-26

Phase 2

Mineralocorticoid Receptor Antagonists (MRA) in Heart Failure (HF) and Loop Diuretic Resistance

CompletedNCT02585843

Columbia UniversityHeart Failure

Start: 2015-11-30End: 2017-03-31Updated: 2019-08-08

Phase 4

Use of Spironolactone for the Prevention of Electrolyte Abnormalities in Patients Treated With Amphotericin B

TerminatedNCT01843309

Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranPatients With Fungic Infections

Start: 2013-05-31End: 2015-03-31Updated: 2015-07-07

Spironolactone for Hidradenitis Suppurativa

WithdrawnNCT04100083

Medical University of South CarolinaHidradenitis Suppurativa

Start: 2020-09-21End: 2021-06-21Updated: 2024-09-19

Unknown Phase

Spironolactone in Covid-19 Induced ARDS

CompletedNCT04345887

Istanbul University - CerrahpasaRespiratory Distress Syndrome, Adult